Diabetes, Diabetes Mellitus, Type 1
Conditions
Brief summary
This study is conducted in Asia. The primary objective of the CDiC programme is to improve access to comprehensive diabetes care among the children with diabetes from the economically underprivileged section of the population and to establish a registry for this group of children with type 1 diabetes in India.
Interventions
DRUGinsulin human
Children will receive conventional treatment with human insulin according to standard medical practice.
Sponsors
Novo Nordisk A/S
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No
Inclusion criteria
* Children diagnosed with type 1 diabetes * Parents/caretakers agree to participate in the study * Child belongs to the below poverty line economic strata (Centre Director certifies economic status for inclusion in to the study)
Exclusion criteria
* Children with type 2 diabetes * Children from higher economic status * Those getting coverage under other government / private schemes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Long-term complications | After 40 months |
| HbA1c (glycosylated haemoglobin) | After 40 months |
| Number of episodes of ketoacidosis | After 40 months |
| Number of episodes of severe hypoglycaemia | After 40 months |
| Patient assessments: Number of days on insulin | After 40 months |
| Number of days with home blood glucose monitoring | After 40 months |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of children who died during the study | After 40 months |
| Percentage of children lost to follow-up | After 40 months |
| Percentage of children with HbA1c equal to or below 8.0 | After 40 months |
Countries
India
Outcome results
None listed